Data Characteristics
mRNA vaccine clinical trial pre-screening data originates from multiple sources: clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), biomedical literature databases (e.g., PubMed, Medline), patent databases, and internal pharmaceutical company reports and research data. Data update frequencies vary. Public registration information typically updates upon trial initiation, major changes, and results publication. Literature data updates with journal publication cycles. Document structures are diverse, including standardized XML or JSON summaries of trial protocols, detailed research reports in PDF format, and unstructured text descriptions. Beyond common fields like trial ID, research institution, and research objective, data includes mRNA vaccine-specific target information, delivery system types, adjuvant components, dosage units (e.g., ug), administration routes, and biomarker data such as immunogenicity and safety.
Constraints on Deployment and Upgrades
The heterogeneous and multi-source nature of mRNA vaccine data requires robust data integration and cleaning capabilities during deployment, especially for unstructured text processing. Asynchronous data updates necessitate flexible data synchronization strategies to balance real-time needs and resource consumption. For instance, critical information sources like ClinicalTrials.gov may require daily incremental synchronization, while literature data could update weekly or monthly. Accurate identification and extraction of specific fields like dosage and adjuvants challenge information extraction model robustness, requiring optimized dictionaries and rules. Furthermore, sensitive clinical data mandates strict data security and privacy protection in the deployment environment, including encrypted data transmission and storage, and access control. During upgrades, new model versions and algorithms may require retraining or fine-tuning to adapt to evolving mRNA vaccine research data characteristics.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Clinical trial protocols or research reports often contain large files with charts and detailed descriptions. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large files and extracting unstructured text takes time; this prevents timeouts. |
maxContext | 3000–4000 characters | mRNA vaccine-related literature and reports have high information density, requiring a longer context window. |
Chunk size | 800–1000 characters | Ensures each data segment contains sufficient semantic information for model comprehension. |
Similarity threshold | Calibrate based on actual measurements | mRNA vaccine target and sequence information have high similarity discrimination, requiring adjustment based on actual data. |
Rerank result count | Top 10 entries | More candidate results are needed for manual review during pre-screening to improve recall. |
Common Pitfalls
- After an upgrade, the system displays an old version number. This can happen if the frontend cache is not refreshed or the deployment script did not correctly update the version identification file.
- Multiple variable update nodes fail to consolidate into a single AI response, resulting in incomplete or logically broken model output. This typically occurs due to improper context transfer mechanism configuration in the workflow design, leading to critical information loss between nodes.
- A MongoDB database version has security vulnerabilities and requires an update but cannot be upgraded directly. This might be due to compatibility issues between the current application version and the new MongoDB version, requiring a review of the FastGPT compatibility matrix or version adaptation testing.
Verification Steps
- Upload and parse a clinical trial PDF document containing mRNA vaccine target, dosage, and adjuvant information. Verify that key fields (e.g.,
target,dosage,佐剂) are accurately extracted and structured. - Execute a pre-screening task with complex query conditions, such as "mRNA vaccine clinical trials targeting SARS-CoV-2 and using lipid nanoparticle delivery systems." Check if the number and relevance of returned results meet expectations and compare them against original data sources.
- Simulate high-concurrency access scenarios. Monitor system resource utilization (CPU, memory, I/O) to ensure stable system performance without significant latency or errors, given the
maxContextandRerank result countparameter settings. - Check system logs to confirm data synchronization tasks execute at the expected frequency and without connection failures, parsing errors, or data loss.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.